{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:52Z","timestamp":1772119972312,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T00:00:00Z","timestamp":1339027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12016-012-8326-y","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T11:01:26Z","timestamp":1338980486000},"page":"47-62","source":"Crossref","is-referenced-by-count":61,"title":["Pathogenic Intracellular and Autoimmune Mechanisms in Urticaria and Angioedema"],"prefix":"10.1007","volume":"45","author":[{"given":"Katherine","family":"Altman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,7]]},"reference":[{"key":"8326_CR1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12016-007-0038-3","volume":"33","author":"MW Greaves","year":"2007","unstructured":"Greaves MW, Tan KT (2007) Chronic urticaria: recent advances. Clin Rev Allergy Immunol 33:134\u2013143","journal-title":"Clin Rev Allergy Immunol"},{"key":"8326_CR2","first-page":"41","volume":"79","author":"KK Guldbakke","year":"2007","unstructured":"Guldbakke KK, Khachemoune A (2007) Etiology, classification, and treatment of urticaria. Cutis 79:41\u201349","journal-title":"Cutis"},{"key":"8326_CR3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11882-009-0040-3","volume":"9","author":"SS Saini","year":"2009","unstructured":"Saini SS (2009) Basophil responsiveness in chronic urticaria. Curr Allergy Asthm Rep 9:286\u2013290","journal-title":"Curr Allergy Asthm Rep"},{"key":"8326_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1469-185X.2009.00105.x","volume":"85","author":"E Crivellato","year":"2010","unstructured":"Crivellato E, Ribatti D (2010) The mast cell: an evolutionary perspective. Biol Rev 85:347\u2013360","journal-title":"Biol Rev"},{"key":"8326_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02686092","volume":"37","author":"M Zhang","year":"2007","unstructured":"Zhang M, Murphy RF, Agrawal DK (2007) Decoding IgE Fc receptors. Immunol Res 37:1\u201316","journal-title":"Immunol Res"},{"key":"8326_CR6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2009.10.007","volume":"128","author":"H Ali","year":"2010","unstructured":"Ali H (2010) Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol Lett 128:36\u201345","journal-title":"Immunol Lett"},{"key":"8326_CR7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2009.03256.x","volume":"39","author":"AP Kaplan","year":"2009","unstructured":"Kaplan AP, Greaves M (2009) Pathogenesis of chronic urticaria. Clin Exp Allergy 39:777\u2013787","journal-title":"Clin Exp Allergy"},{"key":"8326_CR8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.2010.05918.x","volume":"1217","author":"MC Siracusa","year":"2011","unstructured":"Siracusa MC, Comeau MR, Artis D (2011) New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation. Ann NY Acad Sci 1217:166\u2013177","journal-title":"Ann NY Acad Sci"},{"key":"8326_CR9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2222.2011.03781.x","volume":"41","author":"FH Falcone","year":"2011","unstructured":"Falcone FH, Knol EF, Gibbs BF (2011) The role of basophils in the pathogenesis of allergic disease. Clin Exp Allergy 41:939\u2013947","journal-title":"Clin Exp Allergy"},{"key":"8326_CR10","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1016\/j.febslet.2010.08.006","volume":"584","author":"RP Siraganian","year":"2010","unstructured":"Siraganian RP, de Castro RO, Barbu EA, Zhang J (2010) Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett 584:4933\u20134940","journal-title":"FEBS Lett"},{"key":"8326_CR11","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1016\/j.febslet.2010.08.045","volume":"584","author":"V Bugajev","year":"2010","unstructured":"Bugajev V, Bambouskova M, Draberova L, Draber P (2010) What precedes the initial tyrosine phosphorylation of the high affinity IgE receptor in antigen-activated mast cell? FEBS Lett 584:4949\u20134955","journal-title":"FEBS Lett"},{"key":"8326_CR12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1254\/jphs.FM0070251","volume":"106","author":"S Yamasaki","year":"2008","unstructured":"Yamasaki S, Saito T (2008) Progress in allergy signal research on mast cells: signal regulation of multiple mast cell responses through Fc\u03b5RI. J Pharmacol Sci 106:336\u2013340","journal-title":"J Pharmacol Sci"},{"key":"8326_CR13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clim.2009.05.003","volume":"132","author":"SS Saini","year":"2009","unstructured":"Saini SS, Paterniti M, Vasagar K, Gibbons SP, Sterba PM, Vonakis BM (2009) Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: relationship to expression of Syk and SHIP-2. Clin Immunol 132:342\u2013348","journal-title":"Clin Immunol"},{"key":"8326_CR14","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1067\/mai.2001.119159","volume":"108","author":"BM Vonakis","year":"2001","unstructured":"Vonakis BM, Gibbons S, Sora R, Langdon JM, MacDonald SM (2001) Src homology 2 domain-containing inositol 5\u2032 phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J Allergy Clin Immunol 108:822\u2013831","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2006.09.035","volume":"119","author":"BM Vonakis","year":"2007","unstructured":"Vonakis BM, Vasagar K, Gibbons SP et al (2007) Basophil Fc\u03b5RI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 119:441\u2013448","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2222.2006.02494.x","volume":"36","author":"K Vasagar","year":"2006","unstructured":"Vasagar K, Vonakis BM, Gober LM, Viksman A, Gibbons SP, Saini SS (2006) Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exper Allergy 36:770\u2013776","journal-title":"Clin Exper Allergy"},{"key":"8326_CR17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1983.01650320010007","volume":"119","author":"A Lezhoff","year":"1983","unstructured":"Lezhoff A, Jasse RG, Denburg J, Dolovich J (1983) Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 119:636\u2013640","journal-title":"Arch Dermatol"},{"key":"8326_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","volume":"90","author":"BL Gruber","year":"1988","unstructured":"Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP (1988) Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90:213\u2013217","journal-title":"J Invest Dermatol"},{"key":"8326_CR19","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","volume":"328","author":"M Hide","year":"1993","unstructured":"Hide M, Francis DM, Grattan C, Hakimi J, Kochan JP, Greaves MW (1993) Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328:1599\u20131604","journal-title":"N Engl J Med"},{"key":"8326_CR20","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI118325","volume":"96","author":"E Fiebiger","year":"1995","unstructured":"Fiebiger E, Maurer D, Holub H et al (1995) Serum IgG autoantibodies directed against the \u03b1 chain of Fc\u03b5RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 96:2606\u20132612","journal-title":"J Clin Invest"},{"key":"8326_CR21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","volume":"101","author":"E Fiebiger","year":"1998","unstructured":"Fiebiger E, Hammerschmid F, Stingl G, Mauere D (1998) Anti-Fc\u03b5RI\u03b1 autoantibodies in autoimmune-mediated disorders: identification of a structure\u2013function relationship. J Clin Invest 101:243\u2013251","journal-title":"J Clin Invest"},{"key":"8326_CR22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2002.126782","volume":"110","author":"RA Sabroe","year":"2002","unstructured":"Sabroe RA, Fiebiger E, Francis DM et al (2002) Classification of anti-Fc\u03b5RI\u03b1 and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 110:492\u2013499","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR23","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/jid.2010.35","volume":"130","author":"JD Mozena","year":"2010","unstructured":"Mozena JD, Tinana A, Negri J, Steinke JW, Borish L (2010) Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria. J Invest Dermatol 130:1860\u20131865","journal-title":"J Invest Dermatol"},{"key":"8326_CR24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1398-9995.2005.00841.x","volume":"60","author":"MH Platzer","year":"2005","unstructured":"Platzer MH, Grattan CEH, Poulsen LK, Skov PS (2005) Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients. Allergy 60:1152\u20131156","journal-title":"Allergy"},{"key":"8326_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/SMJ.0b013e31820233fc","volume":"104","author":"S Alyasin","year":"2011","unstructured":"Alyasin S, Hamidi M, Karimi AA, Amiri A, Ghaffarpasand F, Ehsaei MJ (2011) Correlation between clinical findings and results of autologous serum skin test in patients with chronic idiopathic urticaria. Southern Med J 104:111\u2013115","journal-title":"Southern Med J"},{"key":"8326_CR26","first-page":"201","volume":"24","author":"K Kulthanan","year":"2006","unstructured":"Kulthanan K, Jiamton S, Gorvanich T, Pinkaew S (2006) Autologous serum skin test in chronic idiopathic urticaria: prevalence, correlation and clinical implications. Asian Pac J Allergy Immunol 24:201\u2013206","journal-title":"Asian Pac J Allergy Immunol"},{"key":"8326_CR27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00005-008-0013-6","volume":"56","author":"AT Khalaf","year":"2008","unstructured":"Khalaf AT, Li W, Jinquan T (2008) Current advances in the management of urticaria. Arch Immunol Ther Exp 56:103\u2013114","journal-title":"Arch Immunol Ther Exp"},{"key":"8326_CR28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2340\/00015555-0240","volume":"87","author":"T Zuberbier","year":"2007","unstructured":"Zuberbier T, Maurer M (2007) Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 87:196\u2013205","journal-title":"Acta Derm Venereol"},{"key":"8326_CR29","first-page":"503","volume":"9","author":"DV Belsito","year":"2010","unstructured":"Belsito DV (2010) Second-generation antihistamines for the treatment of chronic idiopathic urticaria. J Drugs Dermatol 9:503\u2013512","journal-title":"J Drugs Dermatol"},{"key":"8326_CR30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-4632.2005.02609.x","volume":"45","author":"A Kapp","year":"2006","unstructured":"Kapp A, Pichler WJ (2006) Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 45:469\u2013474","journal-title":"Int J Dermatol"},{"key":"8326_CR31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.2005.07049.x","volume":"154","author":"E Nettis","year":"2006","unstructured":"Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A (2006) Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Brit J Dermatol 154:533\u2013538","journal-title":"Brit J Dermatol"},{"key":"8326_CR32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","volume":"125","author":"M Staeveska","year":"2010","unstructured":"Staeveska M, Popov TA, Kralimarkova T et al (2010) The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 125:676\u2013682","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR33","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.jaad.2010.03.007","volume":"63","author":"JB Hong","year":"2010","unstructured":"Hong JB, Lee HC, Hu FC, Chu CY (2010) A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria [letter]. J Am Acad Dermatol 63:e100\u2013e102","journal-title":"J Am Acad Dermatol"},{"key":"8326_CR34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2230.2000.00609.x","volume":"25","author":"NT Watson","year":"2000","unstructured":"Watson NT, Weiss EL, Harter PM (2000) Famotidine in the treatment of acute urticaria. Clin Dermatol 25:186\u2013190","journal-title":"Clin Dermatol"},{"key":"8326_CR35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0196-0644(05)82131-6","volume":"19","author":"RM Moscati","year":"1990","unstructured":"Moscati RM, Moore GP (1990) Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Ann Emerg Med 19:12\u201315","journal-title":"Ann Emerg Med"},{"key":"8326_CR36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0196-0644(05)80881-9","volume":"21","author":"JW Runge","year":"1992","unstructured":"Runge JW, Martinez JC, Caravati EM, Williamson SG, Hartsell SC (1992) Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med 21:237\u2013242","journal-title":"Ann Emerg Med"},{"key":"8326_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/628171","volume":"2010","author":"E Nettis","year":"2010","unstructured":"Nettis E, D\u2019Erasmo M, Di Leo E et al (2010) The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field. Mediat Inflamm 2010:1\u20136","journal-title":"Mediat Inflamm"},{"key":"8326_CR38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","volume":"340","author":"JM Drazen","year":"1999","unstructured":"Drazen JM, Israel E, O\u2019Bryne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197\u2013206","journal-title":"N Engl J Med"},{"key":"8326_CR39","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1365-2222.2001.01189.x","volume":"31","author":"ML Pacor","year":"2001","unstructured":"Pacor ML, Di Lorenzo G, Corrocher R (2001) Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additives and\/or acetylsalicylic acid. Clin Exper Allergy 31:1607\u20131614","journal-title":"Clin Exper Allergy"},{"key":"8326_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.0307-6938.2001.00962.x","volume":"27","author":"E Nettis","year":"2001","unstructured":"Nettis E, Dambra P, D\u2019Oronzio L, Loria MP, Ferrannini A, Tursi BA (2001) Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Clin Exp Dermatol 27:29\u201331","journal-title":"Clin Exp Dermatol"},{"key":"8326_CR41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1067\/mai.2002.126676","volume":"110","author":"Z Erbagci","year":"2002","unstructured":"Erbagci Z (2002) The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 110:484\u2013488","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR42","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","volume":"34","author":"E Nettis","year":"2004","unstructured":"Nettis E, Colanardi MC, Paradiso MT, Ferrannini A (2004) Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 34:1401\u20131407","journal-title":"Clin Exp Allergy"},{"key":"8326_CR43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2004.06.018","volume":"114","author":"G Lorenzo Di","year":"2004","unstructured":"Di Lorenzo G, Pacor ML, Mansueto P et al (2004) Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114:619\u2013625","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR44","first-page":"386","volume":"2","author":"R Asero","year":"2010","unstructured":"Asero R, Tedeschi A (2010) Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol 2:386\u2013390","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8326_CR45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","volume":"143","author":"CEH Grattan","year":"2000","unstructured":"Grattan CEH, O\u2019Donnell BF, Francis DM et al (2000) Randomized double-blind study of cyclosporin in chronic \u2018idiopathic\u2019 urticaria. Brit J Dermatol 143:365\u2013372","journal-title":"Brit J Dermatol"},{"key":"8326_CR46","first-page":"273","volume":"3","author":"RJ Barlow","year":"1993","unstructured":"Barlow RJ, Black AK, Greaves MW (1993) Treatment of severe, chronic urticaria with cyclosporin A. Eur J Dermatol 3:273\u2013275","journal-title":"Eur J Dermatol"},{"key":"8326_CR47","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1997.tb00996.x","volume":"52","author":"E Toubi","year":"1997","unstructured":"Toubi E, Blant A, Kessel A, Golan TD (1997) Low dose cyclosporin A in treatment of severe chronic idiopathic urticaria. Allergy 52:312\u2013316","journal-title":"Allergy"},{"key":"8326_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-009-0084-4","volume":"10","author":"N Daher","year":"2010","unstructured":"Daher N, Lieberman P (2010) Immunosuppression medication as an approach to treat chronic urticaria in children. Curr Allergy Asthma Rep 10:1\u20132","journal-title":"Curr Allergy Asthma Rep."},{"key":"8326_CR49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2009.09538.x","volume":"162","author":"A Perez","year":"2009","unstructured":"Perez A, Woods A, Grattan CEH (2009) Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Brit J Dermatol 162:191\u2013194","journal-title":"Brit J Dermatol"},{"key":"8326_CR50","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archderm.142.10.1337","volume":"142","author":"LY McGirt","year":"2006","unstructured":"McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA (2006) Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol 142:1337\u20131342","journal-title":"Arch Dermatol"},{"key":"8326_CR51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1444-0903.2004.00532.x","volume":"34","author":"GEM Reeves","year":"2004","unstructured":"Reeves GEM, Boyle MJ, Bonfield J, Dobson P, Loewenthal M (2004) Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 34:182\u2013186","journal-title":"Intern Med J"},{"key":"8326_CR52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","volume":"122","author":"AP Kaplan","year":"2008","unstructured":"Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK (2008) Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 122:569\u2013573","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60644-8","volume":"99","author":"SL Spector","year":"2007","unstructured":"Spector SL, Tan RA (2007) Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 99:190\u2013193","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8326_CR54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-7961-9-2","volume":"9","author":"MC Saavedra","year":"2011","unstructured":"Saavedra MC, Sur S (2011) Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Clin Mol Allergy 9:2","journal-title":"Clin Mol Allergy"},{"key":"8326_CR55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.30109","volume":"63","author":"M Boers","year":"2011","unstructured":"Boers M (2011) Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations. Arthritis Rheum 63:329\u2013330","journal-title":"Arthritis Rheum"},{"key":"8326_CR56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2165\/11591480-000000000-00000","volume":"71","author":"DL Scott","year":"2011","unstructured":"Scott DL (2011) Role of spleen tyrosine kinase inhibitors in management of rheumatoid arthritis. Drugs 71:1121\u20131132","journal-title":"Drugs"},{"key":"8326_CR57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.drudis.2010.05.001","volume":"15","author":"M Riccaboni","year":"2010","unstructured":"Riccaboni M, Bianchi I, Petrillo P (2010) Spleen tyrosine kinases: biology, therapeutic targets and drugs. Drug Discov Today 15:517\u2013530","journal-title":"Drug Discov Today"},{"key":"8326_CR58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jaci.2008.04.026","volume":"122","author":"E Mazuc","year":"2008","unstructured":"Mazuc E, Villoutreix BO, Malbec O et al (2008) A novel drug-like spleen tyrosine kinase binder prevents anaphylactic shock when administered orally. J Allergy Clin Immunol 122:188\u2013194","journal-title":"J Allergy Clin Immunol"},{"key":"8326_CR59","doi-asserted-by":"crossref","first-page":"e21117","DOI":"10.1371\/journal.pone.0021117","volume":"6","author":"BO Villoutreix","year":"2011","unstructured":"Villoutreix BO, Laconde G, Lagorce D, Martineau P, Miteva MA, Dariavach P (2011) Tyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screening. PLoS One 6:e21117","journal-title":"PLoS One"},{"key":"8326_CR60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12016-011-8276-9","volume":"41","author":"AM Roquedes-Contios","year":"2011","unstructured":"Roquedes-Contios AM, Misery L (2011) What is intrinsic atopic dermatitis. Clin Rev Allergy Immunol 41:233\u2013236","journal-title":"Clin Rev Allergy Immunol"},{"key":"8326_CR61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","volume":"41","author":"FT Liu","year":"2011","unstructured":"Liu FT, Goodarzi H, Chen HY (2011) IgE, mast cells, eosinophils and atopic dermatitis. Clin Rev Allergy Immunol 41:298\u2013310","journal-title":"Clin Rev Allergy Immunol"},{"key":"8326_CR62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12016-010-8226-y","volume":"41","author":"L Misery","year":"2011","unstructured":"Misery L (2011) Therapeutic perspectives in atopic dermatitis. Clin Rev Allergy Immunol 41:267\u2013271","journal-title":"Clin Rev Allergy Immunol"},{"key":"8326_CR63","doi-asserted-by":"crossref","unstructured":"Di Lorenzo G, Leto-Barone MS, La Piana S, Seidita A, Rini GB (2012) Chronic spontaneous urticaria: an autoimmune disease? A revision of the literature. Clin Exp Med. doi: 10:1007\/s10238-012-0188-3 , E-pub ahead of print","DOI":"10.1007\/s10238-012-0188-3"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8326-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-012-8326-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8326-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:57:16Z","timestamp":1687481836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-012-8326-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,7]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["8326"],"URL":"https:\/\/doi.org\/10.1007\/s12016-012-8326-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717973385.793470092","asserted-by":"object"}]},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,7]]}}}